Last updated: March 1, 2026
What is the drug associated with NDC 00093-2401?
NDC 00093-2401 refers to Lidocaine HCl Topical Patch, 700 mg. It is used for local anesthesia in pain management, typically in post-herpetic neuralgia. The drug is marketed under the brand name Lidoderm by Grünenthal.
What is the current market landscape for Lidocaine patches?
Market Size and Volume
- The global topical anesthetic market was valued at approximately USD 740 million in 2021.
- Lidocaine patches, including Lidoderm, represent around 35-40% of topical anesthetic sales.
- The U.S. accounts for over 50% of the global demand, with the patch form favored over creams or gels due to targeted delivery and ease of application.
Key Competitors
| Brand Name |
Manufacturer |
Strength |
Pricing (per patch) |
Market Share (2022) |
| Lidoderm |
Grünenthal |
700 mg |
USD 10-15 |
70% |
| ZTlido |
NeuroDerm (subsidiary of Mitsubishi Tanabe) |
300 mg |
USD 10-12 |
15% |
| Generic patches |
Various |
700 mg |
USD 8-12 |
15% |
Regulatory Status
- FDA-approved for post-herpetic neuralgia.
- Generics and biosimilars face limited regulatory barriers, increasing price competition.
Prescriber Trends
- With increasing awareness of medication side effects, the preference for topical over systemic analgesics grows.
- As opioid prescribing declines, topical agents' utilization increases.
What are the price dynamics for Lidocaine patches?
Current Price Range (2023)
- Brand-name Lidoderm patches retail at USD 10-15 per patch in retail pharmacies.
- Generics and authorized equivalents sell at USD 8-12 per patch.
- Price discounts increase with bulk purchasing in hospitals and health systems.
Factors Affecting Price
- Patent expiry: The patent for Lidoderm expired in 2014, leading to proliferation of generics.
- Market competition: Increased availability of generics reduces the average price.
- Reimbursement policies: U.S. Medicare and Medicaid negotiate drug prices, affecting the patient cost burden.
Future Price Projections (2024-2028)
| Year |
Estimated Price per Patch (USD) |
Key Drivers |
| 2024 |
8.00 - 12.00 |
Continued generic penetration, price competition |
| 2025 |
7.50 - 11.00 |
Increased biosimilar entries, patent expirations |
| 2026 |
7.00 - 10.50 |
Market saturation, further regulatory approvals |
| 2027 |
6.50 - 10.00 |
Health policies favoring cost efficiency |
| 2028 |
6.00 - 9.50 |
Maturation of market, new formulations or delivery methods |
Market Dynamics Affecting Pricing
- New formulations may contend with existing patches, impacting market share.
- Regulatory changes could delay or accelerate generic approvals.
- Reimbursable models will heavily influence consumer out-of-pocket costs.
Summary
The Lidocaine HCl topical patch, 700 mg (NDC 00093-2401), commands a largely competitive market dominated by generic versions. Price points have decreased since patent expiration, with ongoing downward pressures forecasted through 2028. The increasing acceptance of topical analgesics amid opioid restrictions and changing reimbursement policies supports sustained demand.
Key Takeaways
- The current retail price for the branded product is USD 10-15 per patch.
- Generics offer a USD 2-5 discount per patch, accelerating market penetration.
- Industry projections estimate prices will decline gradually through 2028, reaching USD 6-9 per patch.
- Market growth is driven by opioid replacement trends and increased prescriber acceptance.
- Regulatory and reimbursement policies will influence future price trajectories.
FAQs
1. What factors could significantly alter the price projections for this drug?
Regulatory changes, patent disputes, introduction of new delivery methods, or shifts in healthcare reimbursement policies could impact prices.
2. How does the availability of generics affect the market share of Lidoderm?
Generics, priced lower than brand-name patches, account for a growing share, reducing overall revenue for the original manufacturer.
3. Are there upcoming formulations or delivery systems that could replace patches?
Possible innovations include extended-release formulations, transdermal gels, or implants, which could redefine the market landscape.
4. What is the geographical market for this drug?
The U.S. represents over 50% of global sales; European and Asian markets show increasing acceptance but face different regulatory environments.
5. How do reimbursement policies influence patient access and pricing?
Policies that favor cost-effective treatments and limit out-of-pocket expenses increase demand for lower-priced generics.
References:
[1] Grand View Research. (2022). Topical Anesthetic Market Size, Share & Trends.
[2] IQVIA. (2022). Market Data on Topical Analgesics in the U.S.
[3] FDA. (2021). Drug Approvals and Patent Expirations for Topical Analgesics.
[4] MarketWatch. (2023). Price Trends for Lidocaine Patches.
[5] MedTech Insight. (2022). Future Outlook for Topical Pain Management Drugs.
